What is a reasonable HbA1c (Hemoglobin A1c) target for a patient with type 2 diabetes mellitus on dual Oral Hypoglycemic Agents (OHAs)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board

Educational purpose only • Exercise caution as content is pending human review

Article Review Status

Submitted

Under Review

Approved

Last updated: January 21, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Related Questions

What is the recommended treatment for a patient with a Hemoglobin A1c (HbA1c) level of 7.3%?

What is the best management approach for an adult patient with diabetes mellitus, hypertriglyceridemia, and an HbA1c (hemoglobin A1c) level of 7.7%?

What is the best course of action for a patient with type 2 diabetes, currently on acarbose 50 mg, januvia (sitagliptin) 100 mg, and farxiga (dapagliflozin) 10 mg, whose HbA1c level has increased from 7.1 to 7.2 over the past three months?

What is the best initial sugar medication for a patient with an HbA1c of 7.61?

What is the recommended HbA1c (hemoglobin A1c) target for a patient with type 2 diabetes mellitus (T2DM)?

What is the correct dosing for magnesium citrate in a diabetic patient with hypomagnesemia (magnesium level of 1.44)?

What are the recommended treatment options for a patient with breast cancer or at high risk of developing breast cancer, considering their individual risk factors, medical history, and preferences, as part of the Choosing Wisely (CW) trial for breast cancer management?

How do I use copeptin (C-terminal portion of provasopressin) to differentiate between diabetes insipidus (DI) and primary polydipsia in patients?

What are the management and treatment options for an adult patient with a family history of muscular dystrophy and a confirmed contraction of the D4Z4 repeat array on chromosome 4q35, associated with the DUX4 gene, indicative of facioscapulohumeral muscular dystrophy (FSHD)?

What is the amount of HbA1c (Hemoglobin A1c) reduction achieved by different classes of Oral Hypoglycemic Agents (OHAs) in adult patients with type 2 diabetes mellitus?

What is the recommended treatment approach for a pediatric or young adult patient diagnosed with alveolar rhabdomyosarcoma?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.